Loading clinical trials...
Loading clinical trials...
Sodium glucose co-transporter 2 (SGLT2) inhibitors have revolutionized care for people living with type 2 diabetes mellitus (T2DM). They reduce a person's risk of heart failure, renal failure, myocard...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mount Sinai Hospital, Canada
Collaborators
NCT07374705 · Diabetes Type 2, Diabetes Type 1
NCT05912647 · Diabetes, Diabetes Type 2
NCT07220213 · High Blood Glucose, High Cholesterol, and more
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT07350694 · Diabetes Type 2, Type II Diabetes Mellitus
St. Joseph's Health Centre (Unity Health Toronto)
Toronto, Ontario
Toronto General Hospital (University Health Network)
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions